When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Effects of long-term benzodiazepine use - Wikipedia

   en.wikipedia.org/wiki/Effects_of_long-term...

   [113] [114] Long-term use of benzodiazepines in the elderly can lead to a pharmacological syndrome with symptoms including drowsiness, ataxia, fatigue, confusion, weakness, dizziness, vertigo, syncope, reversible dementia, depression, impairment of intellect, psychomotor and sexual dysfunction, agitation, auditory and visual hallucinations ...

3. Rivaroxaban - Wikipedia

   en.wikipedia.org/wiki/Rivaroxaban

   Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]

4. Direct factor Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Direct_factor_Xa_inhibitors

   Side effects may include bleeding, most commonly from the nose, gastrointestinal tract (GI) or genitourinary system. [2] Compared to the risk of bleeding with warfarin use, direct factor Xa inhibitors have a higher risk of GI bleeding, but lower risk of bleeding in the brain. [2]

5. Battling fatigue: Why veterans are at risk for hormone imbalance

   www.aol.com/battling-fatigue-why-veterans-risk...

   It can cause a lack of sleep, depression, and other metabolic changes associated with low testosterone. ... Symptoms of low T, such as low energy and fatigue, are embarrassing to talk about in ...

6. Johnson & Johnson's Xarelto Loss is AstraZeneca PLC (ADR)'s Gain

   www.aol.com/2014/02/21/johnson-johnsons-xarelto...

   For premium support please call: 800-290-4726 more ways to reach us

7. Discovery and development of direct Xa inhibitors - Wikipedia

   en.wikipedia.org/wiki/Discovery_and_development...

   Rivaroxaban (Xarelto) was the first approved FXa inhibitor to become commercially available in Europe and Canada in 2008. [1] The second one was apixaban (Eliquis), approved in Europe in 2011 [2] and in the United States in 2012. [3] The third one edoxaban (Lixiana, Savaysa) was approved in Japan in 2011 and in Europe and the US in 2015. [4]

8. Syndrome of inappropriate antidiuretic hormone secretion

   en.wikipedia.org/wiki/Syndrome_of_inappropriate...

   In severe or acute hypoosmolar hyponatremia, swelling of brain cells causes various neurological abnormalities, which in severe or acute cases can result in convulsions, coma, and death. The symptoms of chronic syndrome of inappropriate antidiuresis are more vague, and may include cognitive impairment , gait abnormalities , or osteoporosis .

9. Can Lexapro Cause Weight Loss? - AOL

   www.aol.com/lexapro-cause-weight-loss-125700653.html

   For some people, Lexapro can cause weight loss, while for others, it may cause an increase in food intake and weight gain. Below, we’ve covered what Lexapro is, as well as why your mental health ...